Bernhard Gentner

6.6k citations

80 papers · 4.1k indexed · 3 hit papers · h-index 29

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Immunology top 2%
- Immune cells in cancer

Papers in ⓘ

Cancer Research 22
- MicroRNA in disease regulation 18
Hematology 13

Co-authors: Luigi Naldini (47 shared papers)Mario Amendola (5 shared papers)Roberta Mazzieri (5 shared papers)Erika Zonari (11 shared papers)Brian D. Brown (2 shared papers)Davide Moi (3 shared papers)Ferdinando Pucci (3 shared papers)Alice Giustacchini (6 shared papers)
Journals: Blood (16 papers)Molecular Therapy (5 papers)Annals of Oncology (4 papers)EMBO Molecular Medicine (3 papers)Science Translational Medicine (3 papers)
Partner nations: Italy United States Switzerland

In The Last Decade

Bernhard Gentner

75 papers receiving 4.1k citations

Hit Papers

align trajectories log scale

Genotoxic effects of base and prime editing in human hematopoietic stem cells 2023 · 93 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Nature Biotechnology
2014 Nature
2011 Cancer Cell

Peers

Countries citing papers authored by Bernhard Gentner

Since Specialization

Citations

This map shows the geographic impact of Bernhard Gentner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Gentner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Gentner more than expected).

Fields of papers citing papers by Bernhard Gentner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Gentner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Gentner. The network helps show where Bernhard Gentner may publish in the future.

Co-authors

The 25 scholars most cited alongside Bernhard Gentner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernhard Gentner Line = papers co-authored together Bernhard Gentner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells Cancer Cell ·Roberta Mazzieri, Ferdinando Pucci, Davide Moi, Erika Zonari, Anna Ranghetti, Alvise Berti, Letterio S. Politi, Bernhard Gentner, Jeffrey L. Brown, Luigi Naldini, Michele De Palma Hit paper breakdown →	2011	489
2	Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state Nature Biotechnology ·Brian D. Brown, Bernhard Gentner, Alessio Cantore, Silvia Colleoni, Mario Amendola, Anna Zingale, Alessia Baccarini, Giovanna Lazzari, Cesare Galli, Luigi Naldini	2007	449
3	Targeted genome editing in human repopulating haematopoietic stem cells Nature ·Pietro Genovese, Giulia Schiroli, Giulia Escobar, Tiziano Di Tomaso, Claudia Firrito, Andrea Calabria, Davide Moi, Roberta Mazzieri, Chiara Bonini, Michael C. Holmes, Philip D. Gregory, Mirjam van der Burg, Bernhard Gentner, Eugenio Montini, Angelo Lombardo, Luigi Naldini Hit paper breakdown →	2014	434
4	CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma Blood ·Monica Casucci, Benedetta Nicolis di Robilant, Laura Falcone, Barbara Camisa, Margherita Norelli, Pietro Genovese, Bernhard Gentner, Fabiana Gullotta, Maurilio Ponzoni, Massimo Bernardi, Magda Marcatti, Aurore Saudemont, Claudio Bordignon, Barbara Savoldo, Fabio Ciceri, Luigi Naldini, Gianpietro Dotti, Chiara Bonini, Attilio Bondanza	2013	290
5	Stable knockdown of microRNA in vivo by lentiviral vectors Nature Methods ·Bernhard Gentner, Giulia Schira, Alice Giustacchini, Mario Amendola, Brian D. Brown, Maurilio Ponzoni, Luigi Naldini	2008	246
6	Identification of Hematopoietic Stem Cell–Specific miRNAs Enables Gene Therapy of Globoid Cell Leukodystrophy Science Translational Medicine ·Bernhard Gentner, Ilaria Visigalli, Hidefumi Hiramatsu, Eric R. Lechman, Silvia Ungari, Alice Giustacchini, Giulia Schira, Mario Amendola, Angelo Quattrini, Sabata Martino, Aldo Orlacchio, John E. Dick, Alessandra Biffi, Luigi Naldini	2010	159
7	MicroRNA-124 Is a Subventricular Zone Neuronal Fate Determinant Journal of Neuroscience ·Malin Åkerblom, Rohit Sachdeva, Isabelle Barde, Sonia Verp, Bernhard Gentner, Didier Trono, Johan Jakobsson	2012	157
8	Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy Journal of Gastrointestinal Surgery ·Alexander A. Parikh, Bernhard Gentner, Tsung‐Teh Wu, Steven A. Curley, Lee M. Ellis, Jean‐Nicolas Vauthey	2003	155
9	Attenuation of miR-126 Activity Expands HSC In Vivo without Exhaustion Cell stem cell ·Eric R. Lechman, Bernhard Gentner, Peter van Galen, Alice Giustacchini, Massimo Saini, Francesco Boccalatte, Hidefumi Hiramatsu, Umberto Restuccia, Angela Bachi, Véronique Voisin, Gary D. Bader, John E. Dick, Luigi Naldini	2012	154
10	miR-142-3p Prevents Macrophage Differentiation during Cancer-Induced Myelopoiesis Immunity ·Nada Sonda, Francesca Simonato, Elisa Peranzoni, Bianca Calì, Stefania Bortoluzzi, Andrea Bisognin, Ena Wang, Francesco M. Marincola, Luigi Naldini, Bernhard Gentner, Christian Trautwein, Sara Dutton Sackett, Paola Zanovello, Barbara Molon, Vincenzo Bronte	2013	122
11	Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy Stem Cell Reports ·Erika Zonari, Giacomo Desantis, Carolina Petrillo, Francesco Boccalatte, Maria Rosa Lidonnici, Anna Kajaste‐Rudnitski, Alessandro Aiuti, Giuliana Ferrari, Luigi Naldini, Bernhard Gentner	2017	117
12	A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice Blood ·Erika Zonari, Ferdinando Pucci, Massimo Saini, Roberta Mazzieri, Letterio S. Politi, Bernhard Gentner, Luigi Naldini	2013	102
13	Genetic Engineering of Hematopoiesis for Targeted IFN-α Delivery Inhibits Breast Cancer Progression Science Translational Medicine ·Giulia Escobar, Davide Moi, Anna Ranghetti, Pinar Ozkal-Baydin, Mario Leonardo Squadrito, Anna Kajaste‐Rudnitski, Attilio Bondanza, Bernhard Gentner, Michele De Palma, Roberta Mazzieri, Luigi Naldini	2014	94
14	Genotoxic effects of base and prime editing in human hematopoietic stem cells Nature Biotechnology ·Martina Fiumara, Samuele Ferrari, Attya Omer, Stefano Beretta, Luisa Albano, Daniele Canarutto, Angelica Varesi, Chiara Gaddoni, Chiara Brombin, Federica Cugnata, Erika Zonari, Matteo Maria Naldini, Matteo Barcella, Bernhard Gentner, Ivan Merelli, Luigi Naldini Hit paper breakdown →	2023	93
15	Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells Cell stem cell ·Carolina Petrillo, Lucy Thorne, Giulia Unali, Giulia Schiroli, Anna M. Giordano, Francesco Piras, Ivan Cuccovillo, Sarah J. Petit, Fatima Ahsan, Mahdad Noursadeghi, Simon Clare, Pietro Genovese, Bernhard Gentner, Luigi Naldini, Greg J. Towers, Anna Kajaste‐Rudnitski	2018	79
16	Regulated and Multiple miRNA and siRNA Delivery Into Primary Cells by a Lentiviral Platform Molecular Therapy ·Mario Amendola, Laura Passerini, Ferdinando Pucci, Bernhard Gentner, Rosa Bacchetta, Luigi Naldini	2009	73
17	Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells EMBO Molecular Medicine ·Francesco Piras, Michela Riba, Carolina Petrillo, Dejan Lazarević, Ivan Cuccovillo, Sara Bartolaccini, Elia Stupka, Bernhard Gentner, Davide Cittaro, Luigi Naldini, Anna Kajaste‐Rudnitski	2017	55
18	miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic Leukemia Cancer Cell ·Silvia Nucera, Alice Giustacchini, Francesco Boccalatte, Andrea Calabria, Cristiana Fanciullo, Tiziana Plati, Anna Ranghetti, José Manuel García-Manteiga, Davide Cittaro, Fabrizio Benedicenti, Eric R. Lechman, John E. Dick, Maurilio Ponzoni, Fabio Ciceri, Eugenio Montini, Bernhard Gentner, Luigi Naldini	2016	52
19	The galactocerebrosidase enzyme contributes to the maintenance of a functional hematopoietic stem cell niche Blood ·Ilaria Visigalli, Silvia Ungari, Sabata Martino, Hye Jung Park, Martina Cesani, Bernhard Gentner, Lucia Sergi Sergi, Aldo Orlacchio, Luigi Naldini, Alessandra Biffi	2010	51
20	Dual-regulated Lentiviral Vector for Gene Therapy of X-linked Chronic Granulomatosis Molecular Therapy ·Maria Serena Chiriacò, Giada Farinelli, Valentina Capo, Erika Zonari, Samantha Scaramuzza, Gigliola Di Matteo, Lucia Sergi Sergi, Maddalena Migliavacca, Raisa Jofra Hernández, F. Bombelli, Ezio Giorda, Anna Kajaste‐Rudnitski, Didier Trono, Manuel Grez, Paolo Rossi, Andrea Finocchi, Luigi Naldini, Bernhard Gentner, Alessandro Aiuti	2014	49

About Bernhard Gentner

Bernhard Gentner is a scholar working on Cancer Research, Hematology, Immunology, Genetics and Genetics, having authored 80 papers that have together received 4.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (23 papers), Virus-based gene therapy research (21 papers), MicroRNA in disease regulation (18 papers), CRISPR and Genetic Engineering (14 papers), CAR-T cell therapy research (14 papers), Immune cells in cancer (12 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Cancer Research (1.2k citations), Immunology (927 citations), Oncology (1.1k citations), Molecular Biology (2.7k citations) and Genetics (1.0k citations). Bernhard Gentner has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Luigi Naldini, Mario Amendola, Roberta Mazzieri, Erika Zonari, Brian D. Brown, Davide Moi, Ferdinando Pucci, Alice Giustacchini, Letterio S. Politi and Anna Ranghetti. Their work appears in journals such as Blood, Molecular Therapy, Annals of Oncology, EMBO Molecular Medicine and Science Translational Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact